Hospital Acquired Disease Testing : ToC

Key Insights from the Report

Growing Demand for Construction Equipment to Fuel Sales of Undercarriage Components

Largely driven by their application in heavy machinery used in the construction sector, undercarriage components are likely to witness significant growth on the back of rising construction activities worldwide. The construction industry across the globe is expected to present significant opportunities for construction equipment such as crawler excavators, dozers, compact track loaders and crawler cranes. This in turn is anticipated to trigger use of undercarriage components consequently driving their demand and sales. Rising construction projects such as expansion of airports, construction of commercial buildings, growing highway constructions, road extensions and residential have further pushed the demand for heavy machinery in turn supporting the growth of the undercarriage components market during the period of assessment.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Hospital Acquired Disease Testing Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Hospital Acquired Disease Testing Market Analysis and Forecasts, 2017–2027

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Disease Prevalence & Incidence Rate globally with key countries

    5.2. Technological Advancements

6. Global Hospital Acquired Disease Testing Market Analysis and Forecasts, By Test Type 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast By Test Type, 2017–2027

        6.3.1. Urinary Tract Infection

        6.3.2. Surgical Site

        6.3.3. Pneumonia

        6.3.4. Bloodstream

        6.3.5. MRSA

        6.3.6. Others 

    6.4. Market Attractiveness By Test Type 

7. Global Hospital Acquired Disease Testing Market Analysis and Forecasts, By Region

    7.1. Key Findings

    7.2. Market Value Forecast By Region

        7.2.1. North America 

        7.2.2. Europe 

        7.2.3. Asia Pacific 

        7.2.4. Latin America 

        7.2.5. Middle East & Africa 

    7.3. Market Attractiveness By Region

8. North America Hospital Acquired Disease Testing Market Analysis and Forecast

    8.1. Introduction

    8.2. Market Value Forecast By Test Type, 2017–2027

        8.2.1. Urinary Tract Infection

        8.2.2. Surgical Site

        8.2.3. Pneumonia

        8.2.4. Bloodstream

        8.2.5. MRSA

        8.2.6. Others 

    8.3. Market Value Forecast By Country, 2017–2027

        8.3.1. U.S.

        8.3.2. Canada

    8.4. Market Attractiveness Analysis 

        8.4.1. By Test Type 

        8.4.2. By Country

9. Europe Hospital Acquired Disease Testing Market Analysis and Forecast

    9.1. Introduction

    9.2. Market Value Forecast By Test Type, 2017–2027

        9.2.1. Urinary Tract Infection

        9.2.2. Surgical Site

        9.2.3. Pneumonia

        9.2.4. Bloodstream

        9.2.5. MRSA

        9.2.6. Others 

    9.3. Market Value Forecast By Country, 2017–2027

        9.3.1. Germany

        9.3.2. U.K.

        9.3.3. France

        9.3.4. Spain

        9.3.5. Italy

        9.3.6. Rest of Europe

    9.4. Market Attractiveness Analysis 

        9.4.1. By Test Type 

        9.4.2. By Country

10. Asia Pacific Hospital Acquired Disease Testing Market Analysis and Forecast

    10.1. Introduction

    10.2. Market Value Forecast By Test Type, 2017–2027

        10.2.1. Urinary Tract Infection

        10.2.2. Surgical Site

        10.2.3. Pneumonia

        10.2.4. Bloodstream

        10.2.5. MRSA

        10.2.6. Others 

    10.3. Market Value Forecast By Country, 2017–2027

        10.3.1. China

        10.3.2. Japan

        10.3.3. India

        10.3.4. Australia & New Zealand

        10.3.5. Rest of Asia Pacific

    10.4. Market Attractiveness Analysis 

        10.4.1. By Test Type 

        10.4.2. By Country

11. Latin America Hospital Acquired Disease Testing Market Analysis and Forecast

    11.1. Introduction

    11.2. Market Value Forecast By Test Type, 2017–2027

        11.2.1. Urinary Tract Infection

        11.2.2. Surgical Site

        11.2.3. Pneumonia

        11.2.4. Bloodstream

        11.2.5. MRSA

        11.2.6. Others 

    11.3. Market Value Forecast By Country, 2017–2027

        11.3.1. Brazil

        11.3.2. Mexico

        11.3.3. Rest of Latin America

    11.4. Market Attractiveness Analysis 

        11.4.1. By Test Type 

        11.4.2. By Country

12. Middle East & Africa Hospital Acquired Disease Testing Market Analysis and Forecast

    12.1. Introduction

    12.2. Market Value Forecast By Test Type, 2017–2027

        12.2.1. Urinary Tract Infection

        12.2.2. Surgical Site

        12.2.3. Pneumonia

        12.2.4. Bloodstream

        12.2.5. MRSA

        12.2.6. Others 

    12.3. Market Value Forecast By Country, 2017–2027

        12.3.1. GCC Countries

        12.3.2. South Africa

        12.3.3. Rest of Middle East & Africa

    12.4. Market Attractiveness Analysis 

        12.4.1. By Test Type 

        12.4.2. By Country

13. Competition Landscape

    13.1. Abbott Laboratories

        13.1.1. Company Overview (HQ, Business Segments, Employee Strength)

        13.1.2. Financial Overview

        13.1.3. Growth Strategies

        13.1.4. SWOT Analysis

    13.2. Becton, Dickinson and Company

        13.2.1. Company Overview (HQ, Business Segments, Employee Strength)

        13.2.2. Financial Overview

        13.2.3. Growth Strategies

        13.2.4. SWOT Analysis

    13.3. bioMérieux SA

        13.3.1. Company Overview (HQ, Business Segments, Employee Strength)

        13.3.2. Financial Overview

        13.3.3. Growth Strategies

        13.3.4. SWOT Analysis

    13.4. F. Hoffmann-La Roche Ltd.

        13.4.1. Company Overview (HQ, Business Segments, Employee Strength)

        13.4.2. Financial Overview

        13.4.3. Growth Strategies

        13.4.4. SWOT Analysis

    13.5. Hologic, Inc.

        13.5.1. Company Overview (HQ, Business Segments, Employee Strength)

        13.5.2. Financial Overview

        13.5.3. Growth Strategies

        13.5.4. SWOT Analysis

    13.6. Siemens Healthcare

        13.6.1. Company Overview (HQ, Business Segments, Employee Strength)

        13.6.2. Financial Overview

        13.6.3. Growth Strategies

        13.6.4. SWOT Analysis

    13.7. Diatherix Laboratories, Inc.

        13.7.1. Company Overview (HQ, Business Segments, Employee Strength)

        13.7.2. Financial Overview

        13.7.3. Growth Strategies

        13.7.4. SWOT Analysis

    13.8. Meridian Bioscience, Inc.

        13.8.1. Company Overview (HQ, Business Segments, Employee Strength)

        13.8.2. Financial Overview

        13.8.3. Growth Strategies

        13.8.4. SWOT Analysis

    13.9. Thermo Fisher Scientific, Inc.

        13.9.1. Company Overview (HQ, Business Segments, Employee Strength)

        13.9.2. Financial Overview

        13.9.3. Growth Strategies

        13.9.4. SWOT Analysis

List of Table

Table 01 Hospital Acquired Disease Testing Market Size (US$ Mn) Forecast, By Test Type, 2019–2027

Table 02 Hospital Acquired Disease Testing Market Size (US$ Mn) Forecast, By Geography, 2019–2027

Table 03 North America Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Test Type ,2019–2027

Table 04 North America Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Country ,2019–2027

Table 05 Europe Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Test Type ,2019–2027

Table 06 Europe Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Country, 2019–2027

Table 07 Asia Pacific Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Test Type ,2019–2027

Table 08 Asia Pacific Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Country ,2019–2027

Table 09 Latin America Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Test Type ,2019–2027

Table 10 Latin America Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Country ,2019–2027

Table 11 Middle East & Africa Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Test Type ,2019–2027

Table 12 Middle East & Africa Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, By Country ,2019–2027

List of Figure

Figure 01 Hospital Acquired Disease Testing Market Snapshot

Figure 02 Hospital Acquired Disease Testing Market Size (US$ Mn) And Forecast, 2019–2027

Figure 03 Hospital Acquired Disease Testing Market Attractiveness Analysis By Test Type

Figure 04 Hospital Acquired Disease Testing Market Revenue (US$ Mn) And Y-O-Y Growth (%), North America, 2019–2027

Figure 05 Hospital Acquired Disease Testing Market Revenue (US$ Mn) And Y-O-Y Growth (%),Europe, 2019–2027

Figure 06 Hospital Acquired Disease Testing Market Revenue (US$ Mn) And Y-O-Y Growth (%),Asia Pacific, 2019–2027

Figure 07 Hospital Acquired Disease Testing Market Revenue (US$ Mn) And Y-O-Y Growth (%),Latin America, 2019–2027

Figure 08 Hospital Acquired Disease Testing Market Revenue (US$ Mn) And Y-O-Y Growth (%),Middle East & Africa, 2019–2027

Figure 09 North America Hospital Acquired Disease Testing Value Share Analysis, By Test Type, 2019 And 2027

Figure 10 North America Hospital Acquired Disease Testing Value Share Analysis, By Country, 2019 And 2027

Figure 11 Europe Hospital Acquired Disease Testing Value Share Analysis, By Test Type, 2019 And 2027

Figure 12 Europe Hospital Acquired Disease Testing Value Share Analysis, By Country, 2019 And 2027

Figure 13 Asia Pacific Hospital Acquired Disease Testing Value Share Analysis, By Test Type, 2019 And 2027

Figure 14 Asia Pacific Hospital Acquired Disease Testing Value Share Analysis, By Country, 2019 And 2027

Figure 15 Latin America Hospital Acquired Disease Testing Value Share Analysis, By Test Type, 2019 And 2027

Figure 16 Latin America Hospital Acquired Disease Testing Value Share Analysis, By Country, 2019 And 2027

Figure 17 Middle East & Africa Hospital Acquired Disease Testing Value Share Analysis, By Test Type, 2019 And 2027

Figure 18 Middle East & Africa Hospital Acquired Disease Testing Value Share Analysis, By Country, 2019 And 2027